[조사자료] 세계의 암 진단 시장 2024-2030 : 제품별 (소모품, 기기), 유형별 (IVD, LDT), 용도별 (유방암, 폐암), 최종 용도별, 검사 유형별

■ 영문 제목 : Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN058 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 240 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 암 진단 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 암 진단 시장 규모는 2030년까지 1623억1000만 달러에 달할 것으로 예상됩니다. 또한 2024년부터 2030년까지 연평균 6.16%의 성장률을 보일 것으로 예상됩니다. 여러 기관의 암에 대한 인식 개선 프로그램 증가가 전 세계 진단 제품 수요 증가의 주요 요인입니다. 전국 자궁경부암 연합, WHO, CDC, 미국 예방 서비스 작업반 등이 자궁경부암 검진을 늘리기 위해 맺은 파트너십과 협력은 예측 기간 동안 시장 성장을 촉진할 것으로 예상되는 주요 요인 중 하나입니다.

이에 따라 일부 국가에서는 조기 진단을 위한 검진을 늘리고 기존 환자들을 지원하기 위한 조치를 시행하고 있습니다. 예를 들어, Ayushman Bharat와 Prime Minister's National Relief Fund는 치료 중 도움이 필요한 환자를 위해 인도 정부에 의해 시작되었습니다. 마찬가지로 인도 정부의 생명공학부는 영국 암 연구부와 계약을 체결하여 진단 및 치료에 대한 저렴한 접근 방식에 대한 연구를 수행했습니다.

액체 생검 솔루션은 임상 적용이 용이하기 때문에 MCED 검사로 채택되는 경우가 증가하고 있습니다. 최근에는 포괄적이고 다양한 암 진단 접근법으로 규제 당국의 승인을 받고 있습니다. 이 분야의 획기적인 발전과 조기 발견을 위한 지속적인 연구가 시장 성장에 기여하고 있습니다. 또한, 순환 종양 DNA, 세포외 소포, 순환 종양 세포와 같은 기술은 더 나은 암 치료의 길을 열어주고 있습니다. 다재다능한 기술은 액체 생검의 잠재력을 극대화할 수 있는 통합 솔루션을 제공할 수 있습니다.

동반자 진단을 사용하면 제약 및 진단 회사가 부담하는 시간과 비용을 전반적으로 줄일 수 있다는 장점이 있습니다. 새로운 분자의 개발 및 상용화에 소요되는 시간은 일반적으로 10~15년입니다. 진단과 의약품의 공동 개발은 규제 당국의 승인 절차를 촉진하고 비용을 크게 줄일 수 있습니다. 2016년 FDA가 치료제 및 IVD 동반진단제 개발에 대한 가이드라인 초안을 발표한 이후 많은 제조업체들이 암 분야에서 동반진단제 개발을 장려하고 있습니다. 이는 예측 기간 동안 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

암 진단 시장 보고서 하이라이트

- 제품별로는 소모품 부문이 2023년 59.98%로 가장 큰 점유율을 차지하며 예측 기간 동안 가장 빠른 성장률을 보일 것으로 예상됩니다.

- 유형별로는 체외진단(IVD) 부문이 2023년 52.75%의 점유율을 차지했습니다.

- 유방암 응용 분야는 전 국민을 대상으로 한 인식 확산 이니셔티브의 증가와 연구 개발 활동의 증가로 인해 예측 기간 동안 유리하게 성장할 것으로 예상됩니다.

- 최종 용도별로는 효율적인 외래 환자 서비스로 인해 검사실 분야가 시장을 주도하고 있습니다. 병원 분야는 입원 환자 증가로 인해 향후 몇 년 동안 상당한 성장을 보일 것으로 예상됩니다.

- 생검 분야는 질병의 조기 발견을 포함한 검사에 수반되는 다양한 이점으로 인해 상당한 성장률을 보일 것으로 예상됩니다.

- 2023년 글로벌 암 진단 시장, 새로운 진단 검사 승인 증가로 북미 지역이 주도할 것으로 전망됩니다.

- 아시아 태평양 지역은 유병률 증가와 주요 플레이어의 존재로 인해 상당한 성장세를 보일 것으로 예상되고 있습니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 암 진단 시장 변수/동향/범위
4. 세계의 암 진단 시장 규모 : 제품별 비즈니스 분석
5. 세계의 암 진단 시장 규모 : 유형별 비즈니스 분석
6. 세계의 암 진단 시장 규모 : 용도별 비즈니스 분석
7. 세계의 암 진단 시장 규모 : 최종 용도별 비즈니스 분석
8. 세계의 암 진단 시장 규모 : 검사 유형별 비즈니스 분석
9. 세계의 암 진단 시장 규모 : 제품별 비즈니스 분석
10. 세계의 암 진단 시장 규모 : 지역별 비즈니스 분석
11. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Product and Type Snapshot
2.3. Application and End-use Snapshot
2.4. Test Type Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Rising Prevalence of Cancer
3.4.2. Technological Advancements
3.4.3. Rising Initiatives Undertaken by Public and Private Organizations
3.4.4. Extensive R&D for the Development of Novel Testing Solutions
3.5. Market Restraint Analysis
3.5.1. High Cost of Diagnostic Imaging
3.5.2. Radiation Exposure Likely to Limit Usage of CT Scans
3.5.3. Rising Adoption of Refurbished Diagnostic Imaging Systems
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Cancer Diagnostics Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 – 2030 (USD Billion)
4.2.2. Pathology Based-Instruments
4.2.2.1. Slide Staining Systems
4.2.2.1.1. Slide Staining Systems Market, 2018 – 2030 (USD Billion)
4.2.2.2. Tissue Processing Systems
4.2.2.2.1. Tissue Processing Systems Market, 2018 – 2030 (USD Billion)
4.2.2.3. Cell Processors
4.2.2.3.1. Cell Processors Systems Market, 2018 – 2030 (USD Billion)
4.2.2.4. PCR Instruments
4.2.2.4.1. PCR Instruments Market, 2018 – 2030 (USD Billion)
4.2.2.5. NGS Instruments
4.2.2.5.1. NGS Instruments Market, 2018 – 2030 (USD Billion)
4.2.2.6. Microarrays
4.2.2.6.1. Microarrays Market, 2018 – 2030 (USD Billion)
4.2.2.7. Other Pathology-based Instruments
4.2.2.7.1. Other Pathology-based Instruments Market, 2018 – 2030 (USD Billion)
4.2.3. Imaging Instruments
4.2.4. Others
4.3. Consumables
4.3.1. Consumables Market, 2018 – 2030 (USD Billion)
4.4. Services
4.4.1. Services Market, 2018 – 2030 (USD Billion)
Chapter 5. Type Business Analysis
5.1. Cancer Diagnostics Market: Type Movement Analysis
5.2. IVD
5.2.1. IVD Market, 2018 – 2030 (USD Billion)
5.2.2. IVD Market, By Type 2018 – 2030 (USD Billion)
5.2.2.1. Diagnosis
5.2.2.1.1. Diagnosis Market, 2018 – 2030 (USD Billion)
5.2.2.2. Early Detection
5.2.2.2.1. Early Detection Market, 2018 – 2030 (USD Billion)
5.2.2.3. Therapy Selection
5.2.2.3.1. Therapy Selection Market, 2018 – 2030 (USD Billion)
5.2.2.4. Monitoring
5.2.2.4.1. Monitoring Market, 2018 – 2030 (USD Billion)
5.2.3. IVD Market, By Technology 2018 – 2030 (USD Billion)
5.2.3.1. Polymerase Chain Reaction (PCR)
5.2.3.1.1. Polymerase Chain Reaction (PCR) Market, 2018 – 2030 (USD Billion)
5.2.3.2. In Situ Hybridization (ISH)
5.2.3.2.1. In Situ Hybridization (ISH) Market, 2018 – 2030 (USD Billion)
5.2.3.3. Immunohistochemistry (IHC)
5.2.3.3.1. Immunohistochemistry (IHC) Market, 2018 – 2030 (USD Billion)
5.2.3.4. Next-generation Sequencing (NGS)
5.2.3.4.1. Next-generation Sequencing (NGS) Market, 2018 – 2030 (USD Billion)
5.2.3.5. Microarrays
5.2.3.5.1. Microarrays Market, 2018 – 2030 (USD Billion)
5.2.3.6. Flow Cytometry
5.2.3.6.1. Flow Cytometry Market, 2018 – 2030 (USD Billion)
5.2.3.7. Immunoassays
5.2.3.7.1. Immunoassays Market, 2018 – 2030 (USD Billion)
5.2.3.8. Other IVD Testing Technologies
5.2.3.8.1. Other IVD Testing Technologies Market, 2018 – 2030 (USD Billion)
5.3. LDT
5.3.1. LDT Market, 2018 – 2030 (USD Billion)
5.4. Imaging
5.4.1. Imaging Market, 2018 – 2030 (USD Billion)
5.4.2. Magnetic Resonance Imaging (MRI)
5.4.2.1. Magnetic Resonance Imaging (MRI) Market, 2018 – 2030 (USD Billion)
5.4.3. Computed Tomography (CT)
5.4.3.1. Computed Tomography (CT) Market, 2018 – 2030 (USD Billion)
5.4.4. Positron Emission Tomography (PET)
5.4.4.1. Positron Emission Tomography (PET) Market, 2018 – 2030 (USD Billion)
5.4.5. Mammography
5.4.5.1. Mammography Market, 2018 – 2030 (USD Billion)
5.4.6. Ultrasound
5.4.6.1. Ultrasound Market, 2018 – 2030 (USD Billion)
5.4.7. Others
5.4.7.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 6. Application Business Analysis
6.1. Cancer Diagnostics Market: Application Movement Analysis
6.2. Breast Cancer
6.2.1. Breast Cancer Market, 2018 – 2030 (USD Billion)
6.3. Colorectal Cancer
6.3.1. Colorectal Cancer Market, 2018 – 2030 (USD Billion)
6.4. Cervical Cancer
6.4.1. Cervical Cancer Market, 2018 – 2030 (USD Billion)
6.5. Lung Cancer
6.5.1. Lung Cancer Market, 2018 – 2030 (USD Billion)
6.6. Prostate Cancer
6.6.1. Prostate Cancer Market, 2018 – 2030 (USD Billion)
6.7. Skin Cancer
6.7.1. Skin Cancer Market, 2018 – 2030 (USD Billion)
6.8. Blood Cancer
6.8.1. Blood Cancer Market, 2018 – 2030 (USD Billion)
6.9. Kidney Cancer
6.9.1. Kidney Cancer Market, 2018 – 2030 (USD Billion)
6.10. Liver Cancer
6.10.1. Liver Cancer Market, 2018 – 2030 (USD Billion)
6.11. Pancreatic Cancer
6.11.1. Pancreatic Cancer Market, 2018 – 2030 (USD Billion)
6.12. Ovarian Cancer
6.12.1. Ovarian Cancer Market, 2018 – 2030 (USD Billion)
6.13. Others
6.13.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 7. End-Use Business Analysis
7.1. Cancer Diagnostics Market: End-Use Movement Analysis
7.2. Hospitals
7.2.1. Hospitals Market, 2018 – 2030 (USD Billion)
7.3. Laboratories
7.3.1. Laboratories Market, 2018 – 2030 (USD Billion)
7.4. Others
7.4.1. Others Cancer Diagnostics Market, 2018 – 2030 (USD Billion)
Chapter 8. Test Type Business Analysis
8.1. Cancer Diagnostics Market: Test Type Movement Analysis
8.2. Biopsy
8.2.1. Biopsy Market, 2018 – 2030 (USD Billion)
8.2.2. Fine-needle Aspiration
8.2.2.1. Fine-needle Aspiration Market, 2018 – 2030 (USD Billion)
8.2.3. Core Biopsy
8.2.3.1. Core Biopsy Market, 2018 – 2030 (USD Billion)
8.2.4. Surgical Biopsy
8.2.4.1. Surgical Biopsy Market, 2018 – 2030 (USD Billion)
8.2.5. Skin Biopsy /Punch Biopsy
8.2.5.1. Skin Biopsy /Punch Biopsy Market, 2018 – 2030 (USD Billion)
8.2.6. Others
8.2.6.1. Others Market, 2018 – 2030 (USD Billion)
8.3. Others
8.3.1. Others Cancer Diagnostics Market, 2018 – 2030 (USD Billion)
Chapter 9. Product Business Analysis
9.1. Cancer Diagnostics Market: Product Movement Analysis
9.2. Instruments
9.2.1. Instruments Market, 2018 – 2030 (USD Billion)
9.3. Consumables Kits and Reagents
9.3.1. Consumables Kits and Reagents Market, 2018 – 2030 (USD Billion)
9.4. Software and Services
9.4.1. Software and Services Market, 2018 – 2030 (USD Billion)
Chapter 10. Regional Business Analysis
10.1. Cancer Diagnostics Market Share By Region, 2023 & 2030
10.2. North America
10.2.1. North America Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.2.2. U.S.
10.2.2.1. Key Country Dynamics
10.2.2.2. Target Disease Prevalence
10.2.2.3. Competitive Scenario
10.2.2.4. Regulatory Framework
10.2.2.5. Reimbursement Scenario
10.2.2.6. U.S. Cancer diagnostics market, 2018 – 2030 (USD BILLION)
10.2.3. Canada
10.2.3.1. Key Country Dynamics
10.2.3.2. Target Disease Prevalence
10.2.3.3. Competitive Scenario
10.2.3.4. Regulatory Framework
10.2.3.5. Reimbursement Scenario
10.2.3.6. Canada Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3. Europe
10.3.1. Europe Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.2. Germany
10.3.2.1. Key Country Dynamics
10.3.2.2. Target Disease Prevalence
10.3.2.3. Competitive Scenario
10.3.2.4. Regulatory Framework
10.3.2.5. Reimbursement Scenario
10.3.2.6. Germany Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.3. UK
10.3.3.1. Key Country Dynamics
10.3.3.2. Target Disease Prevalence
10.3.3.3. Competitive Scenario
10.3.3.4. Regulatory Framework
10.3.3.5. Reimbursement Scenario
10.3.3.6. UK Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.4. France
10.3.4.1. Key Country Dynamics
10.3.4.2. Target Disease Prevalence
10.3.4.3. Competitive Scenario
10.3.4.4. Regulatory Framework
10.3.4.5. Reimbursement Scenario
10.3.4.6. France Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.5. Italy
10.3.5.1. Key Country Dynamics
10.3.5.2. Target Disease Prevalence
10.3.5.3. Competitive Scenario
10.3.5.4. Regulatory Framework
10.3.5.5. Reimbursement Scenario
10.3.5.6. Italy Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.6. Spain
10.3.6.1. Key Country Dynamics
10.3.6.2. Target Disease Prevalence
10.3.6.3. Competitive Scenario
10.3.6.4. Regulatory Framework
10.3.6.5. Reimbursement Scenario
10.3.6.6. Spain Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.7. Denmark
10.3.7.1. Key Country Dynamics
10.3.7.2. Target Disease Prevalence
10.3.7.3. Competitive Scenario
10.3.7.4. Regulatory Framework
10.3.7.5. Reimbursement Scenario
10.3.7.6. Denmark Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.8. Sweden
10.3.8.1. Key Country Dynamics
10.3.8.2. Target Disease Prevalence
10.3.8.3. Competitive Scenario
10.3.8.4. Regulatory Framework
10.3.8.5. Reimbursement Scenario
10.3.8.6. Sweden Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.3.9. Norway
10.3.9.1. Key Country Dynamics
10.3.9.2. Target Disease Prevalence
10.3.9.3. Competitive Scenario
10.3.9.4. Regulatory Framework
10.3.9.5. Reimbursement Scenario
10.3.9.6. Norway Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4. Asia Pacific
10.4.1. Asia Pacific Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.2. Japan
10.4.2.1. Key Country Dynamics
10.4.2.2. Target Disease Prevalence
10.4.2.3. Competitive Scenario
10.4.2.4. Regulatory Framework
10.4.2.5. Reimbursement Scenario
10.4.2.6. Japan Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.3. China
10.4.3.1. Key Country Dynamics
10.4.3.2. Target Disease Prevalence
10.4.3.3. Competitive Scenario
10.4.3.4. Regulatory Framework
10.4.3.5. Reimbursement Scenario
10.4.3.6. China Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.4. India
10.4.4.1. Key Country Dynamics
10.4.4.2. Target Disease Prevalence
10.4.4.3. Competitive Scenario
10.4.4.4. Regulatory Framework
10.4.4.5. Reimbursement Scenario
10.4.4.6. India Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.5. South Korea
10.4.5.1. Key Country Dynamics
10.4.5.2. Target Disease Prevalence
10.4.5.3. Competitive Scenario
10.4.5.4. Regulatory Framework
10.4.5.5. Reimbursement Scenario
10.4.5.6. South Korea Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.6. Australia
10.4.6.1. Key Country Dynamics
10.4.6.2. Target Disease Prevalence
10.4.6.3. Competitive Scenario
10.4.6.4. Regulatory Framework
10.4.6.5. Reimbursement Scenario
10.4.6.6. Australia Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.4.7. Thailand
10.4.7.1. Key Country Dynamics
10.4.7.2. Target Disease Prevalence
10.4.7.3. Competitive Scenario
10.4.7.4. Regulatory Framework
10.4.7.5. Reimbursement Scenario
10.4.7.6. Thailand Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.5. Latin America
10.5.1. Latin America Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.5.2. Brazil
10.5.2.1. Key Country Dynamics
10.5.2.2. Target Disease Prevalence
10.5.2.3. Competitive Scenario
10.5.2.4. Regulatory Framework
10.5.2.5. Reimbursement Scenario
10.5.2.6. Brazil Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.5.3. Mexico
10.5.3.1. Key Country Dynamics
10.5.3.2. Target Disease Prevalence
10.5.3.3. Competitive Scenario
10.5.3.4. Regulatory Framework
10.5.3.5. Reimbursement Scenario
10.5.3.6. Mexico Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.5.4. Argentina
10.5.4.1. Key Country Dynamics
10.5.4.2. Target Disease Prevalence
10.5.4.3. Competitive Scenario
10.5.4.4. Regulatory Framework
10.5.4.5. Reimbursement Scenario
10.5.4.6. Argentina Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.6. MEA
10.6.1. MEA Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.6.2. South Africa
10.6.2.1. Key Country Dynamics
10.6.2.2. Target Disease Prevalence
10.6.2.3. Competitive Scenario
10.6.2.4. Regulatory Framework
10.6.2.5. Reimbursement Scenario
10.6.2.6. South Africa Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.6.3. Saudi Arabia
10.6.3.1. Key Country Dynamics
10.6.3.2. Target Disease Prevalence
10.6.3.3. Competitive Scenario
10.6.3.4. Regulatory Framework
10.6.3.5. Reimbursement Scenario
10.6.3.6. Saudi Arabia Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.6.4. UAE
10.6.4.1. Key Country Dynamics
10.6.4.2. Target Disease Prevalence
10.6.4.3. Competitive Scenario
10.6.4.4. Regulatory Framework
10.6.4.5. Reimbursement Scenario
10.6.4.6. UAE Cancer diagnostics market, 2018 – 2030 (USD Billion)
10.6.5. Kuwait
10.6.5.1. Key Country Dynamics
10.6.5.2. Target Disease Prevalence
10.6.5.3. Competitive Scenario
10.6.5.4. Regulatory Framework
10.6.5.5. Reimbursement Scenario
10.6.5.6. Kuwait Cancer diagnostics market, 2018 – 2030 (USD Billion)
Chapter 11. Competitive Landscape
11.1. Participant’s overview
11.2. Financial performance
11.3. Participant categorization
11.3.1. Market Leaders
11.3.2. Cancer Diagnostics Market Share Analysis, 2023
11.3.3. Company Profiles
11.3.3.1. ABBOTT
11.3.3.1.1. Company Overview
11.3.3.1.2. Financial Performance
11.3.3.1.3. Product Benchmarking
11.3.3.1.4. Strategic Initiatives
11.3.3.2. GE HEALTHCARE
11.3.3.2.1. Company Overview
11.3.3.2.2. Financial Performance
11.3.3.2.3. Product Benchmarking
11.3.3.2.4. Strategic Initiatives
11.3.3.3. F. HOFFMANN-LA ROCHE LTD.
11.3.3.3.1. Company Overview
11.3.3.3.2. Financial Performance
11.3.3.3.3. Product Benchmarking
11.3.3.3.4. Strategic Initiatives
11.3.3.4. QIAGEN
11.3.3.4.1. Company Overview
11.3.3.4.2. Financial Performance
11.3.3.4.3. Product Benchmarking
11.3.3.4.4. Strategic Initiatives
11.3.3.5. BD
11.3.3.5.1. Company Overview
11.3.3.5.2. Financial Performance
11.3.3.5.3. Product Benchmarking
11.3.3.5.4. Strategic Initiatives
11.3.3.6. SIEMENS HEALTHCARE GMBH
11.3.3.6.1. Company Overview
11.3.3.6.2. Financial Performance
11.3.3.6.3. Product Benchmarking
11.3.3.6.4. Strategic Initiatives
11.3.3.7. THERMO FISHER SCIENTIFIC, INC.
11.3.3.7.1. Company Overview
11.3.3.7.2. Financial Performance
11.3.3.7.3. Product Benchmarking
11.3.3.7.4. Strategic Initiatives
11.3.3.8. HOLOGIC, INC.
11.3.3.8.1. Company Overview
11.3.3.8.2. Financial Performance
11.3.3.8.3. Product Benchmarking
11.3.3.8.4. Strategic Initiatives
11.3.3.9. KONINKLIJKE PHILIPS N.V. (PHILIPS)
11.3.3.9.1. Company Overview
11.3.3.9.2. Financial Performance
11.3.3.9.3. Product Benchmarking
11.3.3.9.4. Strategic Initiatives
11.3.3.10. ILLUMINA, INC.
11.3.3.10.1. Company Overview
11.3.3.10.2. Financial Performance
11.3.3.10.3. Product Benchmarking
11.3.3.10.4. Strategic Initiatives
11.3.4. Strategy Mapping
11.3.4.1. Expansion
11.3.4.2. Acquisition
11.3.4.3. Collaborations
11.3.4.4. Disease Type/Drug Class Launch
11.3.4.5. Partnerships
11.3.4.6. Others

List of Tables

Table 1 List of abbreviations
Table 2 Global cancer diagnostics market, by region, 2018 - 2030 (USD Billion)
Table 3 Global cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 4 Global cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 5 Global cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 6 Global cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 7 Global cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 8 North America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 9 North America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 10 North America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 11 North America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 12 North America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 13 North America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 14 U.S. cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 15 U.S. cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 16 U.S. cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 17 U.S. cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 18 U.S. cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 19 Canada cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 20 Canada cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 21 Canada cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 22 Canada cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Canada cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 24 Europe cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 26 Europe cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 27 Europe cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 28 Europe cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 29 Europe cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 30 UK cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 31 UK cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 32 UK cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 33 UK cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 34 UK cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 35 Germany cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 36 Germany cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 37 Germany cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 38 Germany cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 39 Germany cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 40 France cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 41 France cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 42 France cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 43 France cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 44 France cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 45 Italy cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 46 Italy cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 47 Italy cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 48 Italy cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Italy cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 50 Spain cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 51 Spain cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 52 Spain cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 53 Spain cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 54 Spain cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 55 Denmark cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 56 Denmark cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 57 Denmark cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 58 Denmark cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Denmark cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 60 Sweden cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 61 Sweden cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 62 Sweden cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 63 Sweden cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 64 Sweden cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 65 Norway cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 66 Norway cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 67 Norway cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 68 Norway cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 69 Norway cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 70 Asia Pacific cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 71 Asia Pacific cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 72 Asia Pacific cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 73 Asia Pacific cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 74 Asia Pacific cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 75 Asia Pacific cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 76 Japan cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 77 Japan cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 78 Japan cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 79 Japan cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 80 Japan cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 81 China cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 82 China cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 83 China cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 84 China cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 85 China cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 86 India cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 87 India cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 88 India cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 89 India cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 90 India cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 91 South Korea cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 92 South Korea cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 93 South Korea cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 94 South Korea cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 95 South Korea cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 96 Thailand cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 97 Thailand cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 98 Thailand cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 99 Thailand cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 100 Thailand cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 101 Australia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 102 Australia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 103 Australia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 104 Australia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 105 Australia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 106 Latin America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 107 Latin America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 108 Latin America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 109 Latin America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 110 Latin America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 111 Latin America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 112 Brazil cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 113 Brazil cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 114 Brazil cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 115 Brazil cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 116 Brazil cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 117 Mexico cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 118 Mexico cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 119 Mexico cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 120 Mexico cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 121 Mexico cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 122 Argentina cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 123 Argentina cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 124 Argentina cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 125 Argentina cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 126 Argentina cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 127 Middle East & Africa cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 128 Middle East & Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 129 Middle East & Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 130 Middle East & Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 131 Middle East & Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 132 Middle East & Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 133 South Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 134 South Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 135 South Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 136 South Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 137 South Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 138 Saudi Arabia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 139 Saudi Arabia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 140 Saudi Arabia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 141 Saudi Arabia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 143 UAE cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 144 UAE cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 145 UAE cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 146 UAE cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 147 UAE cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 148 Kuwait cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 149 Kuwait cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 150 Kuwait cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 151 Kuwait cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 152 Kuwait cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)

※본 조사보고서 [세계의 암 진단 시장 2024-2030 : 제품별 (소모품, 기기), 유형별 (IVD, LDT), 용도별 (유방암, 폐암), 최종 용도별, 검사 유형별] (코드 : GRV24JAN058) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 암 진단 시장 2024-2030 : 제품별 (소모품, 기기), 유형별 (IVD, LDT), 용도별 (유방암, 폐암), 최종 용도별, 검사 유형별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 전립선암 진단 시장 (2023-2030) : 예비, 확증
GRV23NOV181 / Grand View Research / 2023년 9월 / 글로벌 전립선암 진단 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 전립선암 진단 시장 규모는 2023년부터 2030년까지 연평균 6. 23%의 성장률로 확대되어 2030년에는 131억 6천만 달러에 달할 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 전립선암 진단 시장 : 검사 유형별 예측 및 동향 분석 Chapter 5. 세계의 전립선암 진단 시장 : 유형별 예측 및 동향 분석 Chapter 6. 세계의 전립선암 진단 시장 : 최종 용도별 예측...

세계의 펩티드 마이크로어레이 시장 (2023~2030) : 질환 진단, 단백질 기능 분석
GRV23MA024 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 펩티드 마이크로어레이 시장 규모가 2023년부터 2030년 사이에 연평균 4.51% 성장하여, 2030년에는 1,133.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 펩티드 마이크로어레이 시장을...Peptide Microarray Market Growth & Trends The global peptide microarray market size is expected to reach USD 1,133.5 million by 2030, registering a CAGR of 4.51% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate...

세계의 맞춤형 항체 시장 (2023~2030) : 단클론 항체, 폴리클로날 항체, 재조합 항체, 기타
GRV23MR076 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 맞춤형 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 301.7백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는 세계의 맞춤형...Custom Antibody Market Growth & Trends The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during...

글로벌 펩티드 약물 복합체 시장 (2023-2030) : 루테튬, 멜플루펜, ANG1005, BT1718, CBX-12, 기타 파이프 라인
GRV23NOV280 / Grand View Research / 2023년 9월 / 글로벌 펩타이드 약물 복합체 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 펩타이드 약물 복합체 시장은 2030년까지 42억 1000만 달러에 달할 것으로 예상되며, 예측 기간 동안 28. 58%의...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 펩티드 약물 복합체 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 펩티드 약물 복합체 시장 : 제품별 예측 및 동향 분석 Chapter 6. 세계의 펩티드 약물 복합체 시장 : 지역별...

세계의 라벨 프리 어레이 시스템 시장 (2023~2030) : 표면 플라즈몬 공명, 생체층 간섭, 세포 유전 분광
GRV23MR110 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 라벨 프리 어레이 시스템 시장 규모가 2023년부터 2030년 사이에 CAGR 7.42% 증가하여, 2030년에는 799.59백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는...Label-free Array System Market Growth & Trends The global label-free array system market size is expected to reach USD 799.59 million by 2030, expanding at a CAGR of 7.42% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial...